Moneycontrol
Jun 19, 2017 10:20 AM IST | Source: Moneycontrol.com

Zydus receives final approval from USFDA for Eletriptan Hydrobromide tablets

Zydus Cadila has received the final approval from the USFDA to market Eletriptan hydrochloride tablets, 20 mg (base) and 40 mg (base).

Zydus receives final approval from USFDA for Eletriptan Hydrobromide tablets
Zydus receives final approval from the USFDA for Eletriptan Hydrobromide TabletsSource : BSE
X
Sections
Follow us on
Available On